|
ATXN3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.791510E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.731200E-01 |
| Normal-vs-Stage2 |
1.553970E-01 |
| Normal-vs-Stage3 |
4.564100E-04 |
| Normal-vs-Stage4 |
7.639800E-03 |
| Stage1-vs-Stage2 |
2.926400E-01 |
| Stage1-vs-Stage3 |
1.844160E-03 |
| Stage1-vs-Stage4 |
2.147800E-02 |
| Stage2-vs-Stage3 |
2.460400E-01 |
| Stage2-vs-Stage4 |
4.418200E-01 |
| Stage3-vs-Stage4 |
7.397400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.710000E-02 |
| Normal-vs-AfricanAmerican |
3.067600E-02 |
| Normal-vs-Asian |
7.648000E-01 |
| Caucasian-vs-AfricanAmerican |
3.757200E-01 |
| Caucasian-vs-Asian |
7.248400E-01 |
| AfricanAmerican-vs-Asian |
4.870800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.980600E-03 |
| Normal-vs-Female |
3.538200E-01 |
| Male-vs-Female |
5.037900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.522000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.567200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.058300E-03 |
| Normal-vs-Age(81-100Yrs) |
1.305150E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.718000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.306600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.703400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.029600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.264800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.920200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.661300E-03 |
| Normal-vs-Grade 2 |
8.146800E-01 |
| Normal-vs-Grade 3 |
9.90180000000063E-05 |
| Normal-vs-Grade 4 |
7.216200E-04 |
| Grade 1-vs-Grade 2 |
3.208900E-04 |
| Grade 1-vs-Grade 3 |
1.35019999625285E-08 |
| Grade 1-vs-Grade 4 |
1.75700000004664E-06 |
| Grade 2-vs-Grade 3 |
4.31750000000619E-05 |
| Grade 2-vs-Grade 4 |
6.027000E-04 |
| Grade 3-vs-Grade 4 |
4.654000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.247400E-01 |
| Normal-vs-ccB subtype |
2.208500E-04 |
| ccA subtype-vs-ccB subtype |
1.03849999999461E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.341500E-02 |
| Normal-vs-N1 |
4.39370000000494E-05 |
| N0-vs-N1 |
2.544200E-02 |
|
|
